Stockfacts
Use CasesDocsPricing
Log inSign up free
OverviewFinancialsTrendsTranscriptsOptionsShortsInstitutionsInsidersCorporate ActionsSEC Filings
Stockfacts

EOD US-equity data for investors and AI agents

Data is end-of-day, not real-time, and not investment advice

Use CasesDashboard

KNSA

Kiniksa Pharmaceuticals International, plc

CIK 0001730430 · Nasdaq

NasdaqHealth CarePharmaceutical Preparations
$79.03
↑ 0.56 (0.71%)
as of Aug 21, 2026
End-of-day close, not real-time intraday
Live price (Google Finance) ↗
Overall read: BullishOverall score · based on 4/4 lenses
FundamentalsOwnershipTechnicalsOptions

Bullish: Fundamentals, Technicals, Options

Key stats

Market Cap
$3.82B
P/E Ratio
52.24
EPS
0.80
Dividend Yield
Not covered
52W Position
92%
Beta
0.21

Valuation multiples

Fwd P/E
71.94
PEG
Not covered
P/B
6.30
P/S
5.06
EV/Revenue
4.81
ROE
12.1%
Valuation data covers 8,711/9,697 US-listed stocks (89.8%).

Price · 1Y

251 trading days

End-of-day close, not real-time intraday

52-Week RangePosition 92%
$32.89$82.94

Latest Financials

2025-12-31 FY
Revenue
$677.56M
Net Income
$59.01M
Total Assets
$763.63M
Free Cash Flow
$136.42M

Recent news